Patient with high-risk GIST not associated with c-KIT mutations: Same benefit from adjuvant therapy?

A patient was diagnosed with neurofibromatosis type 1 (NF1) and gastrointestinal stromal tumour (GIST). This is not simply a coincidence; numerous molecular and genetic studies have established a close relationship between the two disorders, suggesting that GIST should be included in the clinical sp...

Ausführliche Beschreibung